Anavex Life Sciences Has Announced The Date Of The Report For The Financial Year

Anavex Life Sciences is a pharmaceutical company that focuses on the production of drugs for the treatment of diseases of the central nervous system. At the moment, certain drugs aimed at treating Parkinson’s, epilepsy, Angelman syndrome are undergoing scientific research to determine their effectiveness. In general, over the last week, the price of AVXL has decreased by only 0.5%. Although during this period the worth plummeted to $ 21.02, after which it soared 9.2% to $ 22.96. The price has been fluctuating at $ 21.70 for the last 2 days.

The drugmaker said it will release results for the fiscal year ended September 30 on November 24, in other words, a week later. This will be followed by an online conference where, as usual, financial results will be discussed. It will take place at 4:30 pm ET. If you missed the conference for any reason, you can later check out the company’s website. In addition, its CEO is participating in “Exploring the Promise of Novel Therapeutic Approaches,” which will take place today from 10 am to 11 am EST. The goal of the seminar is to win Alzheimer’s disease by 2025, and it’s held annually.